Clinical trials recruiting in Grevenbroich, Germany

Phase breakdown

Conditions recruiting in Grevenbroich, Germany

Recruiting trials in Grevenbroich, Germany

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
  NCT07499232 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
  NCT06294925 · Phase: Not specified · Ages: 18 Years to 64 Years · Sex: All (male and female)
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
  NCT06937086 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
  NCT06937099 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Grevenbroich, Germany?

4 recruiting trials have at least one study site in Grevenbroich, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.